Datos a fecha 06/05/26 11:28
| Ticker | AMRN |
|---|---|
| ISIN | US0231114044 |
| Sector | Atención sanitaria |
| Industria | Biotechnology |
| Mercado | NASDAQ |
| Capitalización | 299.900.223 US$ |
| Beta | 0,82 |
| Sitio web | https://www.amarincorp.com |
| CEO | Aaron D. Berg |
| Fecha de IPO | 01/04/1993 |
| País | IE |
| Dirección | Grand Canal Docklands, Dublin, 2 |
| Volumen | 55.839 |
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialt...
El precio actual de Amarin Corporation (AMRN) es de 14,50 , con una variación del 1,83%.
Amarin Corporation opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones